Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
NRC Health (National Research Corporation, NASDAQ: NRC) generates a steady stream of news focused on healthcare experience management, financial performance, and partnerships with health systems. This news page aggregates updates from company press releases, third-party announcements, and regulatory disclosures so readers can follow how NRC Health is working with healthcare organizations and how its business is evolving over time.
Many NRC Health news items highlight new and expanded partnerships with hospitals and health systems. Recent examples include collaborations with Mosaic Life Care, BJC Health System, North Mississippi Health Services, and South Shore Health. These announcements describe how NRC Health’s patient experience, employee experience, and market insight capabilities are being used to support human-centered care, unify feedback, and guide improvement across hospitals, clinics, and other care settings.
Investors and industry observers will also find coverage of NRC Health’s quarterly results, including revenue trends, Total Recurring Contract Value (TRCV), cash flow from operations, and non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income. These earnings releases often include commentary from company leadership about sales activity, customer retention, and capital allocation through dividends and share repurchases.
Additional news includes leadership appointments, such as executive roles in finance and strategic insights, and recognition related to healthcare experience management, including references to the Best in KLAS Award for Healthcare Experience Management and Excellence in Patient Experience awards given by NRC Health to client organizations. Readers who want to monitor NRC Health’s role in healthcare experience improvement, its relationships with health systems, and its public company disclosures can use this page as a centralized source of updates.
National Research (NRC Health) has released its fourth quarter 2024 financial results, showing revenue of $36.9 million, down from $38.0 million in the same quarter of 2023. Earnings per diluted share decreased to $0.28 from $0.36 year-over-year.
The company reported a net indebtedness of $58.5 million and total recurring contract value (TRCV) of $133.2 million as of December 31, 2024. During the quarter, NRC Health returned $10.1 million to stockholders through dividends and stock repurchases, including approximately 393,000 shares repurchased for $7.3 million and a quarterly dividend of $0.12 per share totaling about $2.8 million.
Renown Health has chosen NRC Health as its strategic partner to enhance patient experience and operational efficiency through human-centered healthcare solutions and data-driven insights. As the largest locally owned not-for-profit healthcare network in northern Nevada, serving over one million people across Nevada, Lake Tahoe, and eastern California, Renown aims to improve several operational aspects including:
- Streamlining manual reporting processes that currently consume significant staff time
- Enhancing service recovery capabilities
- Implementing trusted data and benchmarking for care-team engagement
- Improving CAHPS outreach methods for larger sample sizes
The partnership will leverage NRC Health's comprehensive platform, advanced technology, and AI-powered solutions to create deeper human connections in healthcare delivery while supporting operational effectiveness initiatives.
Signature Healthcare has partnered with NRC Health to enhance its healthcare network through human-centered solutions and data-driven insights. The collaboration aims to improve both patient experience and workforce engagement across Southeastern Massachusetts. Signature Healthcare, a not-for-profit integrated healthcare system, selected NRC Health for its innovative solutions and collaborative approach to healthcare experience management. The partnership focuses on implementing patient experience and employee engagement solutions, leveraging NRC Health's comprehensive platform and AI-powered technology to create deeper human connections in healthcare delivery.
Cooper University Health Care has chosen NRC Health as its new partner for enhancing patient experience across its network. Cooper, serving over 2 million patients annually in Southern New Jersey and Delaware Valley, will utilize NRC Health's comprehensive platform and AI-powered solutions to gain patient insights and deliver human-centered care. The partnership aims to support Cooper's mission of serving, healing, and educating through data-driven insights and humanized healthcare solutions.
National Research (NRC Health) reported its Q3 2024 financial results, showing revenue of $35.8 million, down from $37.9 million in Q3 2023. Earnings per diluted share decreased to $0.24 from $0.32 year-over-year. The company's net indebtedness stood at $50.2 million, with total recurring contract value of $131.6 million. During the quarter, NRC returned $11.5 million to stockholders through dividends ($2.9 million) and stock repurchases ($8.6 million), buying back approximately 395,000 shares. The Board declared a quarterly dividend of $0.12 per share, payable January 10, 2025.
NRC Health, a leader in healthcare experience solutions, unveiled a suite of AI-enabled products at its 30th annual conference, HUB24. The new offerings, powered by the company's secure AI engine Huey, aim to enhance human connections in healthcare. Key announcements include:
1. New AI-powered products: nGage, nQuire, nVolve, nLighten, and nAct, designed to improve patient and employee experiences.
2. Acquisition of Nobl, a leader in advanced rounding solutions for healthcare organizations.
3. Partnership with Medallia to address issues impacting consumer and employee healthcare experiences.
These initiatives reinforce NRC Health's commitment to Human Understanding in healthcare, providing insights to improve patient care and organizational efficiency.
National Research (NRC Health) announced its Q2 2024 results and corporate developments. Revenue decreased to $35 million from $36 million in Q2 2023, while earnings per diluted share dropped to $0.26 from $0.29. The company's net indebtedness stood at $42 million, with a total recurring contract value (TRCV) of $138 million as of June 30, 2024.
NRC Health amended its credit agreement, extending the revolving loan facility maturity to May 28, 2027, and modifying term loan conditions. The company has 1.1 million shares remaining in its stock repurchase plan and declared a quarterly cash dividend of $0.12 per share. Additionally, NRC Health acquired NOBL Health for approximately $6 million, adding $2 million in TRCV. The company is also releasing new consumer and employee experience capabilities, as well as a proprietary AI engine.
National Research , dba NRC Health, (NASDAQ:NRC) announced first quarter 2024 results showing strong growth potential. The CEO highlighted the company's competitive edge in healthcare insights and innovative products. Financially, significant investments were made in technology and teams to support new product launches. The company returned $18 million to stockholders and focused on product innovation and growth investments.
Summary not available.
Summary not available.